WAIKOLOA, Hawaii — In this expert perspective from Retina 2026, Sunir J. Garg, MD, FACS, FASRS, discusses how real-world data have advanced treatment of retinal vascular diseases by increasing the number of available therapy options.
Garg, of Wills Eye Hospital, said patients with age-related macular degeneration or diabetes lose vision due to disease progression or undertreatment. However, the availability of newer therapies has improved anatomic outcomes and helped patients maintain vision.
“Some of our newer treatments would last longer, and that’s very helpful for patients,”